Open access
Jul 2026
Targeted proteomics of postmortem human brain reveals neurobiologic heterogeneity in Alzheimer’s disease using NULISA technology
S. R. Dunlop, Sarah J. Lincoln, MS ZhongweiPeng et al.
· bioRxiv · 0 citations